Skip to content

Prospective, multicenter, self controlled, single group target value clinical trials to evaluate the effectiveness and safety of continuous glucose monitoring systems

Prospective, multicenter, self controlled, single group target value clinical trials to evaluate the effectiveness and safety of continuous glucose monitoring systems

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089452
Enrollment
Unknown
Registered
2024-09-09
Start date
2024-04-09
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

Diabetes group (continued to wear the test instrument for 16 days):No intwevention

Sponsors

Zhongshan Hospital Affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with diabetes, aged 18 years and above, regardless of gender, have stable vital signs.(2) Forearm can establish a venous blood collection pathway.(3) Individuals with hematocrit/hematocrit = 70%.(4) Voluntarily participate in this experiment and sign an informed consent form;

Exclusion criteria

Exclusion criteria: (1) Wearing areas such as the upper arm and abdomen may have skin damage, scars, redness, swelling, or infection.(2) Individuals who are allergic to alcohol disinfectants or medical tape.(3) Individuals with severe bleeding tendencies or abnormal coagulation function (APTT = 1.5 times the upper limit of normal values) during the screening period.(4) Pregnant or lactating women, and those who plan to conceive during the trial period.(5) Have a history of epilepsy or mental illness.(6) Wearing area with swollen skin.(7) Wearing a device that plans to undergo magnetic resonance imaging (MRI), computed tomography (CT), or X-ray examination within 16 days.(8) Individuals who have participated in other intervention device clinical trials or participated in the last drug clinical trial within 5 half-lives within the month prior to the start of this trial.(9) The researchers believe that it is not suitable for participants in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Consistency within the error range of the reference value with the control group;;The proportion of measurement points falling on the Clarke error grid analysis area A+B;The proportion of measurement points located in the A+B area of the Consensus error grid analysis;Mean absolute relative error (MARD%);

Secondary

MeasureTime frame
Alarm accuracy;The stability of the sensor;The repeatability of sensors;Product usability questionnaire survey; Sensor lifespan;Blood glucose data evaluation;Trend accuracy evaluation.;

Countries

China

Contacts

Public ContactXiaoying Li

Zhongshan Hospital Affiliated to Fudan University

Xiaoying_li@Hotmail.com+86 136 5191 3857

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026